Anticoagulants: To bleed or not to bleed, that is the question
Authors:
- Michael SobelMSMichael Sobel
- 1 December 2002
- journal article
- Published by Elsevier in Seminars in Vascular Surgery
- Vol. 15 (4) , 256-267
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Fondaparinux: a synthetic heparin pentasaccharide as a new antithrombotic agentExpert Opinion on Investigational Drugs, 2002
- Heparin modulates integrin function in human plateletsJournal of Vascular Surgery, 2001
- Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and SafetyChest, 2001
- Hemorrhagic Complications of Anticoagulant TreatmentChest, 2001
- Antithrombotic Therapy for Venous Thromboembolic DiseaseChest, 2001
- Heparin reversal by protamine in humans--complement, prostaglandins, blood cells, and hemodynamicsJournal of Applied Physiology, 1991
- Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo.Journal of Clinical Investigation, 1991
- ProtamineAnesthesia & Analgesia, 1985
- Heparin kinetics in venous thrombosis and pulmonary embolism.Circulation, 1976
- Inhibition of Thrombin‐Induced Aggregation of Human Platelets by Heparin and Antithrombin IIIScandinavian Journal of Haematology, 1971